RPAM
Rhenman & Partners Asset Management’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-21,333
| Closed | -$5.02M | – | 94 |
|
|
2015
Q4 | $5.02M | Buy |
21,333
+1,666
| +8% | +$392K | 0.76% | 50 |
|
|
2015
Q3 | $3.11M | Buy |
19,667
+6,534
| +50% | +$1.03M | 0.5% | 63 |
|
|
2015
Q2 | $4.97M | Buy |
13,133
+5,200
| +66% | +$1.97M | 0.6% | 59 |
|
|
2015
Q1 | $3.32M | Sell |
7,933
-3,734
| -32% | -$1.56M | 0.56% | 59 |
|
|
2014
Q4 | $3.19M | Buy |
11,667
+2,467
| +27% | +$675K | 0.93% | 38 |
|
|
2014
Q3 | $1.79M | Sell |
9,200
-4,067
| -31% | -$790K | 0.52% | 80 |
|
|
2014
Q2 | $3.25M | Buy |
13,267
+8,354
| +170% | +$2.05M | 0.96% | 33 |
|
|
2014
Q1 | $1.3M | Sell |
4,913
-1,087
| -18% | -$288K | 0.39% | 75 |
|
|
2013
Q4 | $2.18M | Buy |
+6,000
| New | +$2.18M | 0.85% | 50 |
|